The Na ؉ -Ca 2؉ exchanger (NCX) on the plasma membrane is thought to be the main calcium extrusion system from the cytosol to the extracellular space in many mammalian excitable cells, including cardiac myocytes. However, the pathophysiological role of NCX in the heart is still unclear because of the lack of known specific inhibitors of NCX. To determine the role of NCX in cardiac contraction and the development of cardiac hypertrophy, we imposed pressure overload on the heart of heterozygous NCX knockout (KO) mice by constricting transverse aorta, and examined cardiac function and morphology 3 wk after operation. Although there was no difference in cardiac function between sham-operated KO mice and shamoperated wild-type (WT) mice, KO mice showed higher left ventricular pressure and better systolic function than WT mice in response to pressure overload. Northern blot analysis revealed that mRNA levels of sarcoplasmic reticulum Ca 2؉ -ATPase were reduced by pressure overload in left ventricles of WT but not of KO mice. However, hypertrophic changes with interstitial fibrosis were more prominent in KO mice than WT mice. These results suggest that reduction of NCX results in supernormalized cardiac function and causes marked cardiac hypertrophy in response to pressure
Accumulating evidence suggests that alterations of excitation contraction (EC) coupling cause heart failure (1) . Since cytosolic free calcium ([Ca 2ϩ ] i ) plays a critical role in EC coupling, [Ca 2ϩ ] i levels are tightly regulated by multiple organs in cardiac myocytes. In EC coupling, calcium entering from extracellular space via L-type Ca 2ϩ channels triggers release of calcium from the sarcoplasmic reticulum (SR), which causes a large increase in [Ca 2ϩ ] i and muscle contraction. The increase in [Ca 2ϩ ] i is immediately followed by calcium removal, resulting in muscle relaxation. Calcium removal is accomplished by extrusion to extracellular space by sarcolemmal sodium calcium exchanger (NCX) and by reuptake into SR by the SR calcium pump (SERCA2). Systolic and diastolic dysfunction of the heart may result from disturbed calcium homeostasis with altered content or function of these calciumregulating proteins (2) .
NCX of the plasma membrane is an electrogenic transporter. Three mammalian isoforms of NCX (NCX1, NCX2, and NCX3) have been isolated, and NCX1 is expressed at high levels in the heart (3-8). Extrusion of calcium depends on the concentration of extracellular sodium; the exchange is accomplished in a ratio of three sodium to one calcium, thereby generating an inward current (forward mode). In the initial phase of EC coupling, however, Na ϩ -Ca 2ϩ exchange may occur in the opposite direction (reverse mode) (1, 9) . NCX is thought to contribute ϳ20% of [Ca 2ϩ ] i decrease during relaxation and 80% of calcium movement can be attributed to SERCA2 in cardiac myocytes (9 -11), although this ratio may vary among species during developmental stages and in pathological situations (12-18). Alterations in expression and function of NCX have been reported in pathological hearts of human and animal models (19 -27) . In failing human hearts, expression of NCX has been reported to be increased whereas that of SERCA2 is reduced (22, 23). In contrast, expression of NCX is down-regulated in the heart with hyperthyroidism and that of SERCA2 is increased (26, 27) . Although the significance of Na ϩ -Ca 2ϩ exchange in EC coupling is thought to be important, it is unclear whether the change of expression levels of NCX causes these pathological status because there are no known highly specific inhibitors or stimulators of NCX.
We previously reported that homozygous NCX1-deficient mice die in utero between embryonic day 9 and 10 (28). In null mutant hearts, there exists no forward or reverse mode of the Na ϩ -Ca 2ϩ exchanger activity: the heart does not beat and cardiac myocytes show apoptosis. These findings suggest that NCX1 is required for heartbeat and survival of cardiac myocytes in embryos. To clarify the role of NCX1 in cardiac function and the development of cardiac hypertrophy in response to pressure overload, we analyzed heterozygous mutant of NCX1 knockout (KO) mice. Heterozygous mutant mice were apparently healthy but showed a marked difference in cardiac performance and cardiac hypertrophy vs. wild-type (WT) mice (28).
MATERIALS AND METHODS

Animal models
All protocols were approved by local institutional guidelines. NCX knockout mice were generated as described previously (28). Male heterozygous mutants (KO) and WT littermates of 9-wk-old (21-24 g) were used in the present study. Pressure overload was produced by constricting transverse aorta (29). Mice were anesthetized by intraperitoneal injection of a mixture of ketamine (100 mg/kg) and xylazine (5 mg/kg), and respiration was artificially controlled with a tidal volume of 0.2 ml and a respiratory rate of 110 breaths/min. The transverse aorta was constricted with 7-0 nylon strings by ligating the aorta with a blunted 27 gauge needle, which was removed later. After aortic constriction, the chest was closed and mice were allowed to recover from anesthesia. We confirmed that the magnitude of initial pressure elevation after aortic banding was identical in NCX KO mice and WT mice. The surgeon had no information about the mice used in this study.
Physiological analysis
For catheterization analysis, the right carotid artery was cannulated under anesthesia by a Millar Mikro-Tip transducer with an outer diameter of 0.47 mm (model SPR-612, Millar Instruments, Houston, TX), which was then advanced into the left ventricle. Pressure signals were recorded using a MacLab 3.6/s data acquisition system (AD Instruments, Milford, MA) with a sampling rate of 2000 Hz. Transthoracic echocardiography was performed with HP Image Point (Hewlett Packard, Palo Alto, CA) with a 10 MHz transducer (30). The quantitative measurements represent consensus estimates of two investigators (E.T. and H.T.), and interobserver variability was Ͻ10%. To compare cardiac function among the groups, recordings were made under identical conditions with heart rates at 200 -250 bpm (catheterization and Doppler echo analysis) and at 250 -300 bpm (M mode echo analysis).
Histological analysis
For histological analysis, hearts were fixed with 10% formalin overnight, then embedded in paraffin, sectioned at 4 m thickness, and stained by the Azan method for collagen.
RNA analysis
Total RNA was extracted from left ventricles of mice with RNA ZolB (Teltest Ltd., Porirua, N. Zealand). For Northern blot analysis, 10 g of total RNA was separated on a 1.2% agarose-formaldehyde gel and blotted onto a Hybond-N membrane (Amersham, Little Chalfont, UK). Probes for SERCA2 and the ␣1 subunit of dihydropyridine sensitive Ca 2ϩ channel receptor (DHPR) were as described (32, 33) . cDNA of RyR2 was a gift from Takeshima (Kurume Medical College) (34) . The cDNAs were labeled by random priming with [␣-32 P] dCTP. Quantification of hybridized bands was carried out using Fuji image analyzer (Fujix bas 2000; Fujifilm).
Statistical analysis
Results are expressed as the mean value Ϯ se. Multiple comparisons among three or more groups were carried out by one-way ANOVA and Fisher's exact test for post hoc analysis. A value of P Ͻ 0.05 was considered significant.
RESULTS
Physiological analysis
Pressure study revealed no difference in systolic left ventricular pressure (LVP), end-diastolic pressure (EDP), and positive and negative first derivatives of left ventricular pressure (dP/dt, ϪdP/dt) between shamoperated KO mice and sham-operated WT mice (sham in Table 1 ). Echocardiography also indicated there was no significant difference in cardiac morphology such as interventricular septal wall thickness (IVST), LV posterior wall thickness, LV end-diastolic dimension (LVDd), or LV end-systolic dimension (LVDs) between the two animal groups. Cardiac functions exemplified by ejection fraction (EF), peak early diastolic transmitral velocity (E), E to peak late diastolic transmitral velocity (E/A), and deceleration time of early diastolic transmitral velocity (DCT) of KO mice were not different from those of WT mice. These results suggest that there is no difference in baseline cardiac functions between the two groups.
To elucidate the role of NCX under pathological conditions, we imposed pressure overload on the heart by constricting transverse aorta (TAC) and performed analysis 3 wk after operation. Both mice showed an increase in peak LVP and EDP (Table 1 , Fig. 1A ). The increase in both pressure parameters was more prominent in KO mice than in WT mice. Moreover, dP/dt was significantly increased only in KO and not in WT mice (Table 1 , Fig. 1B ). These data suggest that the heart of KO mice responds more strongly to pressure overload and that cardiac systolic function is enhanced in KO mice in response to pressure overload. Minimal dP/dt, which reflects cardiac relaxant function, was also increased more markedly in KO mice than WT mice (Table 1 , Fig. 1B ). However, KO mice showed a diastolic dip and plateau pattern of LVP, which suggests the existence of 'restrictive' diastolic dysfunction ( Fig. 1A ) (35) . Echocardiography revealed that EF was reduced by TAC in WT but not in KO mice (Table 1) . Although LVDd was enlarged by TAC to the same extent in both WT and KO mice, LVDs was larger in WT than KO mice (Table 1) . LV wall thickness was more increased by TAC in KO mice than in WT mice (Table 1) . LV inflow pattern by Doppler was not changed by TAC in WT mice whereas KO mice showed pseudonormalization of LV inflow pattern characterized by increased E wave and short DCT (Table 1, Fig.  1C ). These results also suggest the existence of restrictive diastolic dysfunction in KO mice (36) .
Histological analysis
There was no significant difference in body weight (BW) among WT and KO mice before or after pressure overload ( Fig. 2) . At 3 wk after TAC, left ventricular weight to BW ratio was increased in both KO and WT mice, but the increase was more prominent in KO vs. WT mice ( Fig. 2A) . Light microscopic analysis revealed there was no fibrosis in the hearts of sham-operated mice of either group; 3 wk after the TAC operation, fibrosis was recognized in the heart of KO mice (Fig. 2B ).
RNA analysis
To determine genetic alterations that underlie these cardiac functional changes by pressure overload, mRNA levels of calcium-regulating proteins were examined by Northern blot analysis. There were no significant differences in ventricular mRNA levels of SERCA2, Systolic LVP, maximal dP/dt, and minimal dP/dt were increased in KO mouse. Diastolic LVP in KO mouse revealed a dip and plateau pattern (arrow). C) Increased peak of E wave with short deceleration time was observed in KO mice. E, Early transmitral velocity; A, late diastolic transmitral velocity due to atrial contraction. DHPR, and RyR2 between sham-operated KO and sham-operated WT mice (Fig. 3) . At 3 wk after TAC, however, expression levels of SERCA2 were significantly reduced in the left ventricle of WT mice but remained unchanged in KO mice (Fig. 3A) . Expression levels of DHPR were decreased by TAC in ventricles of both KO and WT mice to the same extent (Fig. 3B) . Expression levels of RyR2 were not changed by TAC in either KO or WT mice (Fig. 3C) .
DISCUSSION
In the present study, although there was no significant difference in baseline cardiac function between KO and WT mice, KO mice showed more markedly elevated peak LVP than WT mice in response to pressure overload. In WT mice, cardiac functions exemplified by peak dP/dt and EF were deteriorated in response to pressure load. In KO mice, by contrast, these parameters representative of cardiac function were increased. Therefore, the more increased peak LVP in KO mice is not due to procedural bias but to enhanced contractility. In response to pressure overload, the heart develops hypertrophy as an adaptation to reduce wall stress and maintain cardiac function. Both NCX and SERCA2 work in concert to reduce cytosolic Ca 2ϩ levels during diastolic phase, and therefore alterations in expression levels of these proteins may cause cardiac dysfunction (4, 9, 19 -25). Decreased expression of SERCA2 was observed in many models of cardiac hypertrophy and failure (37, 38) . Recent studies demonstrate that NCX is up-regulated in hearts of pressure overload-induced hypertrophy and cardiomyopathy (19 -25). An increase in NCX without a decrease in SERCA2 was reported in human (24) and rabbit (25) hearts with systolic dysfunction. Recently many reports have demonstrated genetically engineered mouse models in which expressions of SR calcium regulatory proteins are modified (39 -42) . Heterozygous mutants of SERCA2 null mice revealed impaired systolic function (39) whereas transgenic mice overexpressing SERCA2 revealed enhanced systolic function (40) . Null mutants of phospholamban, which negatively regulates SERCA2 activity, revealed better cardiac performance (41) but phospholambanoverexpressed mice revealed impaired cardiac function (42) . In this study, NCX mutant mice showed enhanced cardiac function in response to pressure overload. These observations and results suggest that not only a decrease in SERCA2, but also an increase in NCX, may be a cause of depressed systolic performance in the pathological conditions such as pressure overload-induced cardiac hypertrophy or ischemia/perfusion injury.
The release. Northern blot analysis showed that expression levels of DHPR, SERCA2, and RyR2 in the heart of sham-operated KO mice were identical to those of sham-operated WT mice. Northern blot analysis and Western blot analysis revealed that NCX in the heart of heterozygous KO mice was ϳhalf of that of WT mice at mRNA and protein levels (28). The mRNA level of SERCA2 in the left ventricle was reduced in WT hearts but preserved in KO hearts after pressure overload. On the other hand, expression levels of DHPR and RYR2 were similar between WT and KO mice after pressure overload. Earlier studies have shown that expression of NCX is increased and that of SERCA2 is decreased in failing hearts and hypothyroid hearts and that an opposite response is observed in hyperthyroid hearts. Because both proteins are involved in Ca 2ϩ removal from cytoplasm, it seems that an increase in NCX may compensate for less effective SR Ca 2ϩ uptake by a decrease in SERCA2. As pressure overload-induced increase in cytosolic Ca 2ϩ may be enhanced by reduced expression of NCX, there is the possibility these changes may be compensated by up-regulation of SERCA2. Regulatory mechanisms of Ca 2ϩ -handling protein contents (including RyR and DHPR as well as NCX and SERCA2) remain to be determined.
In this study, NCX KO mice showed enhanced cardiac function such as higher LVP, dP/dt, and ϪdP/dt compared with WT mice. These results suggest that a decrease in NCX-driven calcium efflux may cause increases in calcium content in SR and systolic [Ca 2ϩ ] i . An earlier study reported that the SR Ca 2ϩ content of transgenic mice overexpressing NCX was larger than that of wild-type mice (43) . In contrast, in rabbit ventricular myocytes overexpressing NCX, SR Ca 2ϩ content was reduced and fractional shortening of the myocytes by edge detection was impaired (44) . Even though the reason for this discrepancy is not known, since the high [Na ϩ ] i in myocytes of small mammals (i.e., mice and rats) has been reported to favor Ca 2ϩ entry via the reverse mode mechanism of NCX during the action potential (9), the NCX-mediated Ca 2ϩ influx may become pronounced in transgenic animals overexpressing NCX. Therefore, reuptake of Ca 2ϩ into SR during the action potential may be increased despite an enhanced forward mode function of NCX in transgenic mice. Decreased activity of NCX with increased activity of SERCA2 was reported in the rat heart showing hyperthyroidism (27). The results of this study suggest that the decrease in NCX and increase in SERCA2 may underlie the cardiac hyperperformance observed in hyperthyroidism.
Hypertrophied and failing hearts show diastolic dysfunction, which usually results from impairment of both LV relaxation and LV compliance. The process of calcium removal from cytosol determines LV relaxation while structural changes such as interstitial fibrosis and LV wall thickness reduce LV compliance (45) . Since SERCA2 expression levels were reduced in WT mice but not in KO mice, the SR Ca 2ϩ pump activity may be higher in KO than WT mice. Therefore, both a decrease in NCX and an increase in SERCA2 may contribute to the better diastolic relaxation in NCX KO mice. However, catheterization and Doppler echocardiographic analysis revealed that LV compliance was impaired in NCX KO mice in response to pressure overload. Blood pressure was more markedly elevated in KO mice than WT mice, resulting in more marked LV hypertrophy with severe interstitial fibrosis in KO mice. These anatomical changes may cause this type of diastolic dysfunction. In summary, reduced levels of NCX may lead to an increase in cytosolic and SR Ca 2ϩ content, which results in supernormalized systolic and diastolic relaxation function in response to pressure overload. These results suggest that NCX as well as SERCA2 plays a key role in cardiac function in pathological situations. Therefore, reducing NCX function may provide a novel therapeutic approach for heart failure under certain pathological conditions. in heart failure. 
